The Klinique Medical Clinic Public Company Limited Approves Dividend for the Year 2023, Payable on 2 May 2024 - Marketscreener.com
| KLINIQ Stock | 30.75 0.25 0.82% |
About 53% of Klinique Med's investor base is interested to short. The analysis of current outlook of investing in The Klinique Med suggests that many traders are impartial regarding Klinique Med's prospects. The current market sentiment, together with Klinique Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Klinique Med stock news signals to limit their universe of possible portfolio assets.
Klinique |
The Klinique Medical Clinic Public Company Limited Approves Dividend for the Year 2023, Payable on 2 May 2024 Marketscreener.com
Read at news.google.com
 |
Klinique Med Fundamental Analysis
We analyze Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Last Dividend Paid
Last Dividend Paid Comparative Analysis
Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
Klinique Med Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Klinique Med stock to make a market-neutral strategy. Peer analysis of Klinique Med could also be used in its relative valuation, which is a method of valuing Klinique Med by comparing valuation metrics with similar companies.
Peers
Klinique Med Related Equities
| MINT | Minor International | 4.85 | ||||
| AU | After You | 2.80 | ||||
| BDMS | Bangkok Dusit | 0.95 | ||||
| CENTEL | Central Plaza | 0.66 | ||||
| ERW | Erawan | 0.96 |
Complementary Tools for Klinique Stock analysis
When running Klinique Med's price analysis, check to measure Klinique Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klinique Med is operating at the current time. Most of Klinique Med's value examination focuses on studying past and present price action to predict the probability of Klinique Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klinique Med's price. Additionally, you may evaluate how the addition of Klinique Med to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |